| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |